Quince Therapeutics
QNCX
#9114
Rank
NZ$0.13 B
Marketcap
$3.15
Share price
1.14%
Change (1 day)
75.53%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -$1.36

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.47. In 2022 the company made an earnings per share (EPS) of -$2.80 an increase over its 2021 EPS that were of -$5.36.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.36-51.34%
2022-$2.80-47.85%
2021-$5.3615.21%
2020-$4.6662.51%
2019-$2.86179.56%
2018-$1.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.86 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA